In our previous study, we demonstrated that IRF9 inhibits the development of cardiac hypertrophy, and we determined that IRF9 directly interacts with myocardin to suppress its activity and the transcription of SRF (serum response factor) downstream genes in cardiomyocytes19. The gene discussed is IRF9; the disease is cardiac hypertrophy.